Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma.
暂无分享,去创建一个
F. Sonohara | M. Kanda | S. Yamada | T. Fujii | H. Sugimoto | Y. Kodera | S. Nomoto | D. Shimizu | M. Fujiwara | G. Nakayama | M. Koike | Y. Okamura | H. Takami | H. Oya | R. Hashimoto